日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2018/02/23 | 22 : 27 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 06 : 49 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/16 | 06 : 41 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/15 | 08 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/15 | 08 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 07 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 06 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 05 : 51 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 01 : 17 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 01 : 13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 00 : 59 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 00 : 55 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
2018/02/14 | 00 : 53 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |